| Autor: |
Gaggar S; Sameer Gaggar, Nicholas Thompson, Department of Gastroenterology, Freeman Hospital, NE7 7DN Newcastle, United Kingdom., Scott J, Thompson N |
| Jazyk: |
angličtina |
| Zdroj: |
World journal of gastrointestinal pharmacology and therapeutics [World J Gastrointest Pharmacol Ther] 2012 Dec 06; Vol. 3 (6), pp. 97-9. |
| DOI: |
10.4292/wjgpt.v3.i6.97 |
| Abstrakt: |
Gastroduodenal Crohn's disease (CD) is rare and the response to standard medical therapy is often poor. Anti-tumor necrosis factor therapy has revolutionised the treatment of CD. We present a patient with pyloric stenosis associated with CD which improved with Adalimumab therapy. We recommend considering anti-tumor necrosis factor therapy in symptomatic gastroduodenal CD. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
